Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

R&D Systems™ Recombinant Human Bcl-xL (minus C-Terminus) Protein

Catalog No. 894BX050
Change view
Click to view available options
Quantity:
50 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
894BX050 50 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Catalog No. 894BX050 Supplier R&D Systems™ Supplier No. 894BX050
Only null left
Add to Cart
Add to Cart
This item is not returnable. View return policy

Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Inhibition Activity

The Recombinant Human Bcl-xL (minus C-Terminus) Protein is derived from E. coli. The Recombinant Human Bcl-xL (minus C-Terminus) Protein has been validated for the following applications: Inhibition Activity.

Specifications

Formulation Supplied as a 0.2μm filtered solution in HEPES and KCl.
Gene ID (Entrez) 598
Molecular Weight (g/mol) 24 kDa
Name Bcl-xL Minus C-Terminus
Quantity 50 μg
Source E. coli-derived human Bcl-xL protein Ser2-Arg212,with a C-terminal 6-His tag
Storage Requirements Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -70° C as supplied. 3 months, -70° C under sterile conditions after opening.
Conjugate Unconjugated
Recombinant Recombinant
Purity or Quality Grade >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.